Lidokain Aguettant

Lidocaine, the active ingredient in Lidokain Aguettant, is a local anesthetic presented as a sterile solution for infiltration, intradermal and intravenous use. It provides reversible nerve block for minor surgical and diagnostic procedures in patients requiring short‑term anesthesia.

GNH USA supplies Lidokain Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine is a local anesthetic that temporarily blocks nerve conduction for minor procedures and regional techniques.

- Local anesthesia for minor surgical or diagnostic procedures: provides temporary loss of sensation to facilitate the procedure. - Infiltration anesthesia: numbs a specific tissue area before incision or suturing. - Intravenous regional anesthesia (Bier block): creates a reversible nerve block in a limb for short surgeries.

Lidocaine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Tingling or numbness at the injection site. - Mild dizziness or light‑headedness. - Transient headache. - Nausea or mild gastrointestinal upset. - Localized swelling or erythema.

Serious or Rare Side Effects: - Central nervous system toxicity (e.g., seizures, altered mental status). - Cardiovascular effects such as arrhythmias or hypotension. - Allergic reactions including rash, urticaria, or anaphylaxis. - Methemoglobinemia, especially with high doses. - Persistent numbness or motor weakness beyond the expected duration.

When using Lidokain Aguettant, consider the following safety measures.

- Patient assessment: evaluate for known hypersensitivity to amide‑type local anesthetics. - Dose calculation: ensure total administered dose does not exceed recommended maximums for the patient’s weight and age. - Cardiac monitoring: observe patients with pre‑existing heart disease or those receiving large volumes. - Concurrent CNS depressants: use caution when combined with other agents that may lower seizure threshold. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as safety data are limited. - Store at ambient temperature: keep below 25°C, in the original container, protected from moisture and direct sunlight.

Lidocaine can interact with several medications, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase risk of cardiotoxicity. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise plasma lidocaine levels. - Beta‑blockers: may potentiate cardiovascular depression.

Moderate Interactions (Monitor Closely): - Other local anesthetics: cumulative toxicity risk. - CNS depressants (e.g., benzodiazepines, opioids): may enhance sedation and seizure risk. - Diuretics: may affect plasma protein binding, altering free lidocaine concentration.